Shareholders' equity · 2011–2025
Vanda Pharmaceuticals shareholders' equity
$327M−39.2% · FY2025
Vanda Pharmaceuticals (VNDA) reported $327M in shareholders' equity for fiscal 2025, −39.2% year on year.
| Fiscal year | Shareholders' equity | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $327M | −39.2% | Open → |
| FY20242024-12-31 | $539M | −1.2% | Open → |
| FY20232023-12-31 | $545M | +3.4% | Open → |
| FY20222022-12-31 | $527M | +4.4% | Open → |
| FY20212021-12-31 | $505M | +11.4% | Open → |
| FY20202020-12-31 | $453M | +10.3% | Open → |
| FY20192019-12-31 | $411M | +49.2% | Open → |
| FY20182018-12-31 | $275M | +109.6% | Open → |
| FY20172017-12-31 | $131M | +0.0% | Open → |
| FY20162016-12-31 | $131M | −1.3% | Open → |
| FY20152015-12-31 | $133M | −17.3% | Open → |
| FY20142014-12-31 | $161M | +264.5% | Open → |
| FY20132013-12-31 | $44.1M | +345.5% | Open → |
| FY20122012-12-31 | $9.9M | −70.4% | Open → |
| FY20112011-12-31 | $33.5M | — | Open → |
Shareholders' equity — Shareholders' equity is what remains after subtracting liabilities from assets — the accounting book value of the company, not its market value.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +17.7%
Shareholders' equity at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Vanda Pharmaceuticals shareholders' equity |url=https://companiesranked.com/en/company/vanda-pharmaceuticals/shareholders-equity |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Vanda Pharmaceuticals shareholders' equity. CompaniesRanked. https://companiesranked.com/en/company/vanda-pharmaceuticals/shareholders-equityBibTeX
@misc{companiesranked-en-company-vanda-pharmaceuticals-shareholders-equity-2026,
author = {{CompaniesRanked}},
title = {{Vanda Pharmaceuticals shareholders' equity}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/vanda-pharmaceuticals/shareholders-equity}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001628280-26-053855 · August 6, 2026
{{cite web |title=Vanda Pharmaceuticals shareholders' equity — 10-Q (0001628280-26-053855) |url=https://www.sec.gov/Archives/edgar/data/1347178/000162828026053855/vnda-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-06}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.